Kaleidex Group has confirmed a strategic investment to support the relocation and expansion of OxDevice Medical operations into a new, purpose-designed facility at Monarch House, Abingdon Science Park.
The move will see OxDevice Medical consolidate its existing operations from three separate buildings into a single, modern site, strengthening capacity and creating a platform for future growth. The relocation reflects Kaleidex’s continued investment in its group businesses, enabling infrastructure-led expansion while maintaining continuity for customers.
Refurbishment work at Monarch House will commence in early 2026, with office teams and R&D capabilities transferring first, followed by the completion of new cleanroom and specialist laboratory facilities. Validation activities will be completed before production resumes fully in the new facility.
Throughout the transition, OxDevice’s priority remains maintaining service continuity and avoiding disruption to customer programmes, with phased planning and proactive communication already underway, and OxDevice teams working closely with partners to manage schedules and maintain delivery commitments. OxDevice recently passed a full recertification of the whole quality system for ISO 13485 and has cleanroom certification for ISO 14644.
Gavin Meadows, Chief Executive Officer of Kaleidex, said:
“This investment demonstrates our commitment to backing the long-term growth of OxDevice. Bringing teams and capabilities together into a single, modern facility strengthens operational resilience today while creating the foundations for future capability expansion. It is a considered, practical step in our broader ambition to build factories of the future across the Kaleidex Group.”
New facility, evolving infrastructure
The new facility at Monarch House will provide increased space, improved workflows, and enhanced infrastructure to support higher volumes and evolving technical requirements, including:
- Clean room manufacturing, including microscopic assembly
- Dedicated other manufacturing space for packaging
- Nitinol wire forming, shape setting, braiding, laser cutting and electropolishing
- Elastomeric and lubricious coatings for neuro and vascular devices, e.g. silicone
- New R&D space and a new laboratory for the product design and development engineering team
- Project management area, including digital screens linked to the planning software
- Expansion of the quality control room
- Expansion of the stores area and a loading area
- Large break room with a digital screen to join online group meetings and expanded administrative space, including a board room and a meeting room.
Praveen Sagar, Technical Director at OxDevice Medical, added:
“Consolidating into one site gives us greater control over our processes and environment. The new cleanrooms and laboratories will support both current programmes and the development of new capabilities, while allowing us to operate more efficiently as demand grows.”
The relocation reinforces Kaleidex’s strategy of strengthening acquired businesses through targeted investment, modern infrastructure, and careful integration supporting sustainable growth across the Group.
